| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |